Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayano Mori

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmaceutical Research|September 21, 2022
Human Hepatic Transporter Signature Peptides for Quantitative Targeted Absolute Proteomics: Selection, Digestion Efficiency, and Peptide StabilityAyano Mori, Takeshi Masuda, Shingo Ito, et al.
Chemical Communications (Cambridge, England)|September 15, 2005
Liquid imidazole-borane complexNoriyoshi Matsumi, Ayano Mori, Kenji Sakamoto, et al.
Drug Metabolism and Pharmacokinetics|October 24, 2020
Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkersTakeshi Masuda, Ayano Mori, Shingo Ito, et al.
Japanese Journal of Ophthalmology|November 26, 2003
A case of uveal, palpebral, and orbital invasions in adult T-Cell leukemiaAyano Mori, Hiroko Eida Deguchi, Kazuaki Mishima, et al.
Molecular Pharmaceutics|September 9, 2020
Proteomic Evaluation of Plasma Membrane Fraction Prepared from a Mouse Liver and Kidney Using a Bead Homogenizer: Enrichment of Drug-Related Transporter ProteinsRyotaro Yagi, Takeshi Masuda, Seiryo Ogata, et al.
Journal of Investigative Medicine High Impact Case Reports|March 20, 2024
Pericardial Effusion in Association With Periodontitis: Case Report and Review of 8 Patients in LiteratureToshihiko Matsuo, Chie Nakago Matsuo, Nobuhiko Matsuo, et al.
International Journal of Rheumatic Diseases|November 21, 2025
Overweight Impairs Escalating Optimal Methotrexate Dose and Effect via Liver Dysfunction in Japanese Patients With Rheumatoid ArthritisSoshi Takahashi, Miho Shibata, Miho Takahashi, et al.
Archives of Rheumatology|April 16, 2026
Early Erythrocyte Methotrexate Polyglutamate-4 Predicts Treatment Response and Is Influenced by GGH 401C>T Genotype in Patients with Rheumatoid ArthritisMiho Takahashi, Soshi Takahashi, Ayano Mori, et al.
Journal of Pharmaceutical Sciences|November 7, 2020
Transient, Tunable Expression of NTCP and BSEP in MDCKII Cells for Kinetic Delineation of the Rate-Determining Process and Inhibitory Effects of Rifampicin in Hepatobiliary Transport of TaurocholateSumito Ito, Wooin Lee, Ji Eun Park, et al.
Plos One|December 14, 2020
Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritisAyano Mori, Toshiharu Saito, Miho Takahashi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmaceutical Research|September 21, 2022
Human Hepatic Transporter Signature Peptides for Quantitative Targeted Absolute Proteomics: Selection, Digestion Efficiency, and Peptide StabilityAyano Mori, Takeshi Masuda, Shingo Ito, et al.
Chemical Communications (Cambridge, England)|September 15, 2005
Liquid imidazole-borane complexNoriyoshi Matsumi, Ayano Mori, Kenji Sakamoto, et al.
Drug Metabolism and Pharmacokinetics|October 24, 2020
Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkersTakeshi Masuda, Ayano Mori, Shingo Ito, et al.
Japanese Journal of Ophthalmology|November 26, 2003
A case of uveal, palpebral, and orbital invasions in adult T-Cell leukemiaAyano Mori, Hiroko Eida Deguchi, Kazuaki Mishima, et al.
Molecular Pharmaceutics|September 9, 2020
Proteomic Evaluation of Plasma Membrane Fraction Prepared from a Mouse Liver and Kidney Using a Bead Homogenizer: Enrichment of Drug-Related Transporter ProteinsRyotaro Yagi, Takeshi Masuda, Seiryo Ogata, et al.
Journal of Investigative Medicine High Impact Case Reports|March 20, 2024
Pericardial Effusion in Association With Periodontitis: Case Report and Review of 8 Patients in LiteratureToshihiko Matsuo, Chie Nakago Matsuo, Nobuhiko Matsuo, et al.
International Journal of Rheumatic Diseases|November 21, 2025
Overweight Impairs Escalating Optimal Methotrexate Dose and Effect via Liver Dysfunction in Japanese Patients With Rheumatoid ArthritisSoshi Takahashi, Miho Shibata, Miho Takahashi, et al.
Archives of Rheumatology|April 16, 2026
Early Erythrocyte Methotrexate Polyglutamate-4 Predicts Treatment Response and Is Influenced by GGH 401C>T Genotype in Patients with Rheumatoid ArthritisMiho Takahashi, Soshi Takahashi, Ayano Mori, et al.
Journal of Pharmaceutical Sciences|November 7, 2020
Transient, Tunable Expression of NTCP and BSEP in MDCKII Cells for Kinetic Delineation of the Rate-Determining Process and Inhibitory Effects of Rifampicin in Hepatobiliary Transport of TaurocholateSumito Ito, Wooin Lee, Ji Eun Park, et al.
Plos One|December 14, 2020
Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritisAyano Mori, Toshiharu Saito, Miho Takahashi, et al.
Pageof 2